2nd Tumor Myeloid-Directed Therapies Summit
Designed for experts working directly on myeloid-directed therapies, and those in adjacent immuno-oncology fields, from cell therapy to checkpoint and engager development, featuring the CRH's Professor Jeff Pollard.
-
2nd Tumor Myeloid-Directed Therapies Summit
Returning in 2022, the Tumor Myeloid-Directed Therapeutics Summit is the only industry-focused meeting dedicated to unlocking novel therapeutic potential through the myeloid compartment.
Boston, MA, United States